Analysis Version
v1
History
Back
causal
Analysis v1
Strong Support

Giving men the normal amount of testosterone their bodies should have doesn't make them more likely to get prostate cancer.

1
Pro
0
Against

Evidence from Studies

Supporting (1)

1

Community contributions welcome

1

Testosterone deficiency and treatments: common misconceptions and practical guidance for patient care.

Narrative Review
Human
2025 Jul 3

This study looked at whether giving men the right amount of testosterone to fix low levels causes prostate cancer — and found no proof that it does. So, the claim is right: safe, normal-dose testosterone therapy doesn’t raise cancer risk.

Contradicting (1)

0

Community contributions welcome

1

Testosterone Replacement, Where Are We in 2025?

Narrative Review
Human

The article talks about how testosterone therapy is safer and easier to use now, but it doesn’t say whether it causes or doesn’t cause prostate cancer — so we can’t tell if the claim is right or wrong from this study.

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Similar Assertions

Studies with lots of people and strict methods show that giving men testosterone at normal body levels doesn’t make them more likely to die or have serious heart problems.

78
0
85%

Giving men the right amount of testosterone to bring their levels back to normal doesn’t make their heart worse — and might even help their metabolism and blood sugar.

55
0
84%

For men between 55 and 67, taking testosterone therapy doesn’t seem to increase their chances of getting prostate cancer compared to men who don’t take it, based on a long-term study of nearly 3,000 men.

53
0
80%

For men who have low testosterone, giving them testosterone therapy doesn’t seem to make prostate cancer more likely, so doctors can feel more confident using it when it’s properly needed.

1
0
80%

Men between 55 and 67 who take testosterone therapy may be almost half as likely to die from prostate cancer as men who don’t take it, based on a long-term study.

53
0
78%

Related Content